NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 226 citations · Khurshid Guru
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
The New England journal of medicine · 2023 · 285 citations · Gabriel Haas
The current landscape of single-port robotic surgery in urology.
Nature reviews. Urology · 2026 · 29 citations · Firas Abdollah, Craig Rogers, Ash Tewari, Ketan Badani
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.
The New England journal of medicine · 2026 · 37 citations · Gabriel Haas
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 259 citations · Khurshid Guru
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 267 citations · Gabriel Haas
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
JAMA · 2025 · 56 citations · Ash Tewari
Lower Urinary Tract Symptoms in Men: A Review.
JAMA · 2025 · 45 citations · Casey Brodsky